Treatment Effectiveness
User reported effectiveness ratings 5-Methyltetrahydrofolate (5-MTHF) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Methylenetetrahydrofolate Reductase Deficiency | 50% | 17% | 0% | 33% | 0% | 6 |
| Peripheral Neuropathy | 33% | 0% | 0% | 67% | 0% | 3 |
Outcomes
Below is the degree of change seen after 5-Methyltetrahydrofolate (5-MTHF) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
5-Methyltetrahydrofolate (5-MTHF) Info
| Property | Value |
|---|---|
| Variable Name | 5-methyltetrahydrofolate (5-MTHF) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-05-06 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 92157 |